Search Results 251-260 of 17356 for Uveitis

  1. Surgery - Doctors - Mayo Clinic

    Alexander R. Shusko, Jr., M.D.. Ophthalmologist. Phoenix, AZ. Areas of focus: Cataract surgery, Dry eyes, Cataract, Uveitis ...

  2. Surgery - Doctors - Mayo Clinic

    Shusko, Jr., M.D.. Ophthalmologist. Phoenix, AZ. Areas of focus: Cataract surgery, Cataract, Dry eyes, Uveitis. Rafael J. Sierra, M.D..

  3. UBX1325 for Treatment of Neovascular ARMD - Mayo Clinic

    History of uveitis;; Vitreomacular traction;; Clinically significant epiretinal membrane (ERM);; Aphakia or Anterior Chamber Intraocular Lens (A/C IOL);; Other ...

  4. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

    granulomatosis; myasthenia gravis; Graves' disease; rheumatoid arthritis; hypophysitis; uveitis; etc) within the past 3 years prior to the start of treatment.

  5. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Subject has a history of uveitis (within the last year prior to Screening) or clinically confirmed diagnosis of macular edema. Subject has a known active ...

  6. Surgery - Doctors - Mayo Clinic

    Shusko, Jr., M.D.. Ophthalmologist. Phoenix, AZ. Areas of focus: Cataract surgery, Cataract, Dry eyes, Uveitis. Rafael J. Sierra, M.D..

  7. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

    Patients with immunotherapy related myocarditis, colitis, uveitis, or pneumonitis are excluded. Patients with other immunotherapy related adverse events ...

  8. Tofacitinib is first oral medication approved for use in treating moderate to severe ulcerative colitis - Mayo Clinic

    ... uveitis." Other JAK inhibitors such as upadacitinib and filgotinib are being studied in phase II and III studies of UC and Crohn's disease. Both of these ...

  9. Surgery - Doctors - Mayo Clinic

    Shusko, Jr., M.D.. Ophthalmologist. Phoenix, AZ. Areas of focus: Cataract surgery, Cataract, Dry eyes, Uveitis. Rafael J. Sierra, M.D..

  10. A Study to Evaluate Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC - Mayo Clinic

    ... uveitis, etc]). The following are exceptions to this criterion: Subjects with vitiligo or alopecia;; Subjects with hypothyroidism (e.g., following Hashimoto ...